spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

TP3 Global receives Royal recognition by winning the Queen’s Awards for Enterprise 2018

TP3 Global


Birmingham, UK, 23 April 2018 – TP3 Global, a leading global innovator and provider of thermal protection for temperature sensitive cargo, is pleased to announce it has been awarded the 2018 Queen’s Awards for Enterprise in the International Trade category for its globally-recognised Silverskin™ brand.

The Queen’s Awards for Enterprise are the United Kingdom’s most prominent business awards, which commend enterprise excellence. TP3 Global won the recognition for outstanding growth in overseas sales over the past three years. SilverSkinTM has become a major brand in the market, recognised, approved and used by the leading pharmaceutical companies around the world. TP3 Global has seen rapid growth thanks to a strong focus on providing consistent quality and innovative solutions to a worldwide client base.

Clive Wheeldon, President of TP3 Global, commented: “We are extremely proud to achieve the prestigious Queen’s Award for Enterprise for international trade. Our commitment to providing market-leading products, innovation and high-quality customer service has resulted in working with the industry’s leading pharmaceutical companies.

 “We continue to invest heavily in R&D, global footprint and customer service ensuring we stay at the forefront of the market. We are delighted to see many of the world’s pharmaceutical companies utilise SilverskinTM to maintain the integrity of their products in their supply chain. Our team is very proud to have won a prestigious Queen’s Award that recognises our on-going commitment to innovation and excellence for international trade.”

 The Queen’s Awards for Enterprise first began in 1966. They are awarded to businesses for outstanding achievement in four categories International Trade, Innovation, Sustainable Development and also for Promoting Opportunity (through social mobility).



phone 01962 435006
email lisa@amplify-pr.co.uk
web www.tp3global.com
 
Print this page
Send to a friend
   
spacer
News and Press Releases

BioIVT Webinar Will Discuss How to Optimize Microbiome Research

BioIVT, a leading provider of research models and services for drug development, today announced that it is hosting a webinar entitled “The Microbiome: Understanding Why Collection and Processing Matters” at 11 a.m. ET on July 25.
More info >>


White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

Industry Events

Pharmaceutical Packaging and Device Labelling Europe

11-12 September 2018, Munich, Germany

Relaunching the event after a three year hiatus, Pharma Packaging and Labelling Europe is back to deliver key, actionable insight on the very latest regulatory requirements, technological innovations, strategic developments, and how to implement them into your packaging and labelling chain with both maximum efficiency and minimal cost. The conference is packed with thought provoking innovative discussions.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement